Safety of infraorbital hyaluronic acid injections: Outcomes of a meta-analysis on prospective clinical trials.
Andreas NikolisKaitlyn M EnrightPhilippe BerrosJohn S SamaplisPublished in: Journal of cosmetic dermatology (2023)
The incidence rates of adverse events following the administration of hyaluronic acid injections in the infraorbital region vary depending on whether a needle or cannula is used; with needles being associated with a greater risk of ecchymosis and cannulas being associated with a greater risk of edema. These findings should be discussed with patients prior to treatment consultation. Finally, as with most techniques, it is usually prudent to develop expertise with one technique before using a second, especially in cases where both approaches can be used and have different adverse event profiles.
Keyphrases
- hyaluronic acid
- clinical trial
- end stage renal disease
- ultrasound guided
- newly diagnosed
- ejection fraction
- chronic kidney disease
- palliative care
- platelet rich plasma
- risk factors
- type diabetes
- peritoneal dialysis
- randomized controlled trial
- emergency department
- adipose tissue
- skeletal muscle
- intensive care unit
- obstructive sleep apnea
- weight loss
- phase iii